Skip to main content
Icon - Person in the Lab

Better Diagnostics For Better Living

At Tosoh Bioscience - Diagnostics EMEA, we empower labs with innovative solutions in immunochemistry, HPLC, and molecular biology, helping you deliver faster, more accurate answers when every result counts.

EXPLORE HPLC SOLUTIONS EXPLORE IMMUNOASSAY SOLUTIONS

Explore Products

Tosoh Bioscience Diagnostics provides solutions designed to support a broad spectrum of diagnostic needs. 

Discover targeted solutions tailored to diverse clinical needs — each engineered to elevate performance, streamline workflows, and improve outcomes.

CLINICAL SPECIALTIES

  • Diabetes
  • Thyroid
  • Tumor
  • Reproductive
  • Cardiac
  • Metabolic
  • Vitamin D
  • Kidney
  • Sepsis
  • Lung Function
VIEW ALL DIAGNOSTIC SOLUTIONS

Media

    Hemoglobin Variants Library

    The online library to enhance HPLC-based hemoglobinopathy interpretation

    Tosoh Bioscience - Diagnostics EMEA is committed to improving healthcare through innovation and education. As a pioneer in diabetes monitoring and hemoglobinopathy diagnosis, Tosoh has created a library of chromatograms to support biologists and technicians by harnessing the experience and expertise of the global scientific community.  

    The Hemoglobin Variants Library represents a significant advancement to continue providing cutting-edge interpretation tools for better diagnostics. 

    Visit the Tosoh Support Portal

    Hemoglobin Variants Library Logo

    Featured Products

    1 A I A 900 340x255

    AIA-900

    The AUTOMATED ENZYME IMMUNOASSAY ANALYZER AIA-900 is an automated analyzer that measures a variety of substances in serum| plasma| and urine using the AIA-PACK reagent series.

    View Product

    The Challenge in ILD Management

    Interstitial Lung Diseases (ILD) represent a heterogeneous group of pulmonary disorders involving varying degrees of interstitial inflammation, cellular proliferation, and fibrosis within the alveolar wall. 

    These conditions are often associated with complex imaging patterns, making diagnosis and monitoring challenging. A major hurdle in the management of ILDs remains the lack of robust, accessible biomarkers to track disease progression and treatment response. 

    Learn more about KL-6

     

    Challenge in ILD Management

    Product Support

    ISO Certificates

      Back to top